Helping clients meet their business challenges begins with an in-depth understanding of the industries in which they work. That’s why KPMG LLP established its industry-driven structure. In fact, KPMG LLP was the first of the Big Four firms to organize itself along the same industry lines as clients.

How We Work

We bring together passionate problem-solvers, innovative technologies, and full-service capabilities to create opportunity with every insight.

Learn more

Careers & Culture

What is culture? Culture is how we do things around here. It is the combination of a predominant mindset, actions (both big and small) that we all commit to every day, and the underlying processes, programs and systems supporting how work gets done.

Learn more

Industry Series: Transfer Pricing for Life Sciences

02.24.2023 | Duration: 16:57

Exploring Transfer Pricing Episode 02-2023 | Don’t be blinded by science. Open your eyes to the often complex and always fascinating world of transfer pricing in the life sciences industry!

Listen now
Backward 10s Play Pause Forward 10s

Podcast overview

Like life itself, the life sciences industry is expansive and constantly evolving, which is why keeping up with the cutting edge of developments and understanding the dynamic implications is crucial to practicing transfer pricing in this industry. Often times, the ever-changing regulatory landscape, from both tax and scientific perspectives, present unique challenges to this industry. For instance, how to define intellectual property in this industry is not always straightforward… should it be limited to formulas, or have there been breakthroughs in the development of novel manufacturing processes that should be protected? Also, how does a company appropriately divide the profits amongst the entities involved in often a decades long development cycle? That is a particularly onerous task – but one that must be addressed by, you guessed it, transfer pricing.

The answers to these questions all have implications on taxable outcomes, and transfer pricing is central to this analysis. While we focus on the pharmaceutical sector in this episode, you will come to appreciate how much more there is to learn about this industry and the various sub-sectors.

As part of our Industry Series, Exploring Transfer Pricing tours different industries with specialists to discuss some of what makes their industry of focus unique, and how that might impact the transfer pricing.

Our host Brittany Hardin Tanguay welcomes Molly Minnear (Principal and Senior Industry Lead for Life Sciences) and Rui Che (Managing Director, Tax - Economic and Valuation Services) both based out of Philadelphia, to introduce the life sciences (pharmaceutical) industry in the context of transfer pricing.


Meet our podcast team

Image of Brittany Hardin Tanguay
Brittany Hardin Tanguay
Manager, Tax, Washington National Tax - Rotations, KPMG US
Image of Rui Che
Rui Che
Managing Director, Tax, Economic & Valuation Services, KPMG US

Discover more podcast episodes in this series

More Exploring transfer pricing podcast episodes

Explore more

Thank you!

Thank you for contacting KPMG. We will respond to you as soon as possible.

Contact KPMG

Use this form to submit general inquiries to KPMG. We will respond to you as soon as possible.

By submitting, you agree that KPMG LLP may process any personal information you provide pursuant to KPMG LLP's Privacy Statement.

An error occurred. Please contact customer support.

Job seekers

Visit our careers section or search our jobs database.

Submit RFP

Use the RFP submission form to detail the services KPMG can help assist you with.

Office locations

International hotline

You can confidentially report concerns to the KPMG International hotline

Press contacts

Do you need to speak with our Press Office? Here's how to get in touch.